MedPath

IRCCS SAN RAFFAELE ROMA SRL

🇮🇹Italy
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.poliambulatorisanraffaele.it/it/sedi/san-raffaele-pisana

Clinical Trials

371

Active:26
Completed:116

Trial Phases

5 Phases

Phase 1:6
Phase 2:27
Phase 3:14
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (127 trials with phase data)• Click on a phase to view related trials

Not Applicable
73 (57.5%)
Phase 2
27 (21.3%)
Phase 3
14 (11.0%)
Phase 4
7 (5.5%)
Phase 1
6 (4.7%)

Optimization of Oocyte Warming Protocols

Not Applicable
Active, not recruiting
Conditions
Oocyte Cryopreservation
First Posted Date
2025-08-06
Last Posted Date
2025-08-06
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
399
Registration Number
NCT07105891
Locations
🇮🇹

IRCCS San Raffaele Hospital, Milan, Lombardia, Italy

BURDEN OF ESOPHAGEAL CANCER IN EOSINOPHILIC ESOPHAGITIS (ESCAPE STUDY)

Active, not recruiting
Conditions
Eosinophilic Esophagitis (EoE)
First Posted Date
2025-08-03
Last Posted Date
2025-08-03
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
100000
Registration Number
NCT07102329
Locations
🇮🇹

IRCCS San Raffaele Hospital, Milan, Lombardia, Italy

Feasibility and Effectiveness of Three-day Discharge After Distal Pancreatectomy

Not yet recruiting
Conditions
Pancreatic Neoplasms
Distal Pancreatectomy (DP)
First Posted Date
2025-07-31
Last Posted Date
2025-08-07
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
35
Registration Number
NCT07095621

The Embryo-endometrium Multifaceted Interface: Endometrial Cavity Molecular Microbiobial and Transcriptomic Signatures in Predictinf Pregnancy Outcome in Infertile Patients Undergoing Assisted Reproduction Technology Procedures

Active, not recruiting
Conditions
Infertility (IVF Patients)
First Posted Date
2025-07-25
Last Posted Date
2025-07-25
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
322
Registration Number
NCT07085585
Locations
🇮🇹

OSR Innate Immunity and tissue remodeling Unit and Centro Scienze Natalità OS, Milano, Italy

This Protocol Focuses on the Factors That Influence Survival, the Development of Complications and the Quality of Life Based on the Treatment Received in the Group of Patients Suffering From Malignant Lesions of the Head and Neck

Not yet recruiting
Conditions
Head and Neck Cancer
First Posted Date
2025-07-15
Last Posted Date
2025-07-15
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
400
Registration Number
NCT07066878
Locations
🇮🇹

Ospedale San Raffaele, Milan, Italy

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 75
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.